Correlation Between Intracellular and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Intracellular and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intracellular Th and Pacira BioSciences,, you can compare the effects of market volatilities on Intracellular and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Pacira BioSciences,.

Diversification Opportunities for Intracellular and Pacira BioSciences,

0.6

Correlation Coefficient

Intracellular  Pacira BioSciences,

Poor diversification

The 3 months correlation between Intracellular and Pacira is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Intracellular i.e., Intracellular and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Intracellular and Pacira BioSciences,

Given the investment horizon of 90 days Intracellular Th is expected to generate 0.89 times more return on investment than Pacira BioSciences,. However, Intracellular Th is 1.12 times less risky than Pacira BioSciences,. It trades about 0.13 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.08 per unit of risk. If you would invest  7,300  in Intracellular Th on September 1, 2024 and sell it today you would earn a total of  1,265  from holding Intracellular Th or generate 17.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Intracellular Th  vs.  Pacira BioSciences,

Intracellular Th

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pacira BioSciences,

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pacira BioSciences, may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Intracellular and Pacira BioSciences,

The main advantage of trading using opposite Intracellular and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Intracellular Th and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.